ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021
Electronically Available Patient Claims Data Improve Models for Comparing Antibiotic Use Across Hospitals: Results From 576 US Facilities.
Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Estimating the likelihood of hospitalists to repeatedly prescribe high rates of antibiotics.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2025Article
- Performance of Risk Models for Antimicrobial Resistance in Adult Patients With Sepsis.JAMA network open · 2024Article
- A Novel Risk-Adjusted Metric to Compare Hospitals on Their Antibiotic Prescribing at Hospital Discharge.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024Article
- Evaluating racial and ethnic disparities in antibiotic treatment for pneumonia patients in a major academic health system.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2024Article
- Clinical, contextual and hospital-level factors associated with escalation and de-escalation of empiric Gram-negative antibiotics among US inpatients.JAC-antimicrobial resistance · 2023Article
- Patterns, Predictors, and Intercenter Variability in Empiric Gram-Negative Antibiotic Use Across 928 United States Hospitals.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023Article
- The CDC antimicrobial use measure is not ready for public reporting or value-based programs.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2023Article
- Is the standardized antibiotic administration ratio (SAAR) ready for prime time?Antimicrobial stewardship & healthcare epidemiology : ASHE · 2023Article
- National Healthcare Safety Network Antimicrobial Use Option reporting … finding the path forward.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2023Article
- Hospital-onset bacteremia and fungemia: An evaluation of predictors and feasibility of benchmarking comparing two risk-adjusted models among 267 hospitals.Infection control and hospital epidemiology · 2022Article
- Learning Causal Effects From Observational Data in Healthcare: A Review and Summary.Frontiers in medicine · 2022Review
- Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic.Open forum infectious diseases · 2021Article
- Development of a Machine Learning Model Using Electronic Health Record Data to Identify Antibiotic Use Among Hospitalized Patients.JAMA network open · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundThe Centers for Disease Control and Prevention (CDC) uses standardized antimicrobial administration ratios (SAARs)-that is, observed-to-predicted ratios-to compare antibiotic use across facilities. CDC models adjust for facility characteristics when predicting antibiotic use but do not include patient diagnoses and comorbidities that may also affect utilization. This study aimed to identify comorbidities causally related to appropriate antibiotic use and to compare models that include these comorbidities and other patient-level claims variables to a facility model for risk-adjusting inpatient antibiotic utilization.
methodsThe study included adults discharged from Premier Database hospitals in 2016-2017. For each admission, we extracted facility, claims, and antibiotic data. We evaluated 7 models to predict an admission's antibiotic days of therapy (DOTs): a CDC facility model, models that added patient clinical constructs in varying layers of complexity, and an external validation of a published patient-variable model. We calculated hospital-specific SAARs to quantify effects on hospital rankings. Separately, we used Delphi Consensus methodology to identify Elixhauser comorbidities associated with appropriate antibiotic use.
resultsThe study included 11 701 326 admissions across 576 hospitals. Compared to a CDC-facility model, a model that added Delphi-selected comorbidities and a bacterial infection indicator was more accurate for all antibiotic outcomes. For total antibiotic use, it was 24% more accurate (respective mean absolute errors: 3.11 vs 2.35 DOTs), resulting in 31-33% more hospitals moving into bottom or top usage quartiles postadjustment.
conclusionsAdding electronically available patient claims data to facility models consistently improved antibiotic utilization predictions and yielded substantial movement in hospitals' utilization rankings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.